CureVac AG

CureVac AG Firmenkenndaten im Überblick

Product Range

No product launch yet

Key Research Areas CureVac AG

Prophylactic vaccines for infectious diseases, cancer immunotherapy, molecular therapy, adjuvants ( each mRNA-based)
(All data based on corporate information from member CureVac AG , as of: 10/2015)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
The Pharmaceutical Industry in Germany

Germany: The Perfect Location for Research, Production and Sales - a publication by GERMANY TRADE & INVEST and vfa
Brochure Download